Christine Källén joins Scandinavian Biopharma as our new VP Quality Assurance

Scandinavian Biopharma has in November appointed Christine Källén as VP Quality Assurance and she will supersede Annette Elmqvist, who is retiring at the end of the year.

Christine’s career spans over more than 20 years in quality assurance. Most recently Christine worked at the Swedish Nuclear Fuel and Waste Management Company, SKB, where she was the coordinator and handled SKB’s requirements system and traceability. Prior to that, Christine worked as project manager at Octapharma where she was the responsible validation leader for projects within sterile production, control and monitoring systems. She was responsible for the development of quality systems, risk assessments, audits and equipment validation.

Christine also has a background in QA at Pharmacia and at SBL Vaccin.

– I look forward to the development of the first diarrhoeal vaccine protecting both travellers and children under five against disease caused by the ETEC bacteria.

Christine’s solid industry experience fits Scandinavian Biopharma requirements perfectly and she will play a major role in our late phase development project ETVAX®, says Björn Sjöstrand, CEO Scandinavian Biopharma. I would also like to take the opportunity to express my gratitude to Annette for her dedication and her contribution to the great development of Scandinavian Biopharma.



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.